PE/Cyanine7 anti-human IgD Antibody
- 产品名称：
- PE/Cyanine7 anti-human IgD Antibody
- 产品类别：
- 抗体
- 产品编号：
- 348209
- 产品应用：
- 348209
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1908 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Human IgD
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunohistochemical staining of paraformaldehyde fixed frozen sections4?and spatial biology (IBEX)5,6.
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Chen K, et al. 2009. Nat. Immunol. 10:889.
- Lee CH, et al. 2005. J. Exp. Med. 203:63.
- Sutter JA, et al. 2008. Clin. Immunol. 126:282.
- Li H and Pauza CD. 2015. Eur. J. Immunol. 45:298. (IHC)
- Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
- Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
- Product Citations
-
- Rouers A, et al. 2021. Cell Rep Med. 2:100278. PubMed
- Lagou V et al. 2018. Cell reports. 25(3):798-810 . PubMed
- van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
- Ahmed R et al. 2019. Cell. 177(6):1583-1599 . PubMed
- Lindner JM, et al. 2019. Immunity. 50:668. PubMed
- Cao Y, et al. 2022. Nature. :. PubMed
- Pape KA, et al. 2021. Cell Rep. 37:109823. PubMed
- Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
- Cho A, et al. 2019. Cell Rep. 28:909. PubMed
- Alhaj Hussen K, et al. 2017. Immunity. 47:680. PubMed
- Pape KA, et al. 2022. JCI Insight. 7:. PubMed
- Bradley T et al. 2018. Cell. 175(2):387-399 . PubMed
- Mudd PA, et al. 2022. Cell. 185:603. PubMed
- Rouers A, et al. 2021. iScience. 24:102482. PubMed
- Imura Y, et al. 2020. JCI Insight. :5. PubMed
- Friedensohn S, et al. 2018. Front Immunol. 9:1401. PubMed
- RRID
- AB_10683460 (BioLegend Cat. No. 348209) AB_10680462 (BioLegend Cat. No. 348210)
- Structure
- Exists in a transmembranal and a soluble form
- Distribution
-
Na?ve B cells
- Function
- Antigen binding, B cell activation
- Interaction
- The CD79a/CD79b heterodimer
- Cell Type
- B cells
- Biology Area
- Immunology
- Antigen References
-
1. Geisberger R, et al. 2006. Immunology 118:429.
2. Weller S, et al. 2005. Eur. J. Immunol. 35:2789.
3. Brandtzaeg P and Johansen FE. 2005. Immunol. Rev. 206:32.
- Gene ID
- 3495 View all products for this Gene ID
- UniProt
- View information about IgD on UniProt.org
